- Home
- CLSD vs ELVA Comparison
CLSD vs ELVA Comparison
Compare CLSD & ELVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLSD
- ELVA
- Stock Information
- Founded
- CLSD 2011
- ELVA 1996
- Country
- CLSD United States
- ELVA Canada
- Employees
- CLSD N/A
- ELVA N/A
- Industry
- CLSD Biotechnology: Pharmaceutical Preparations
- ELVA
- Sector
- CLSD Health Care
- ELVA
- Exchange
- CLSD Nasdaq
- ELVA Nasdaq
- Market Cap
- CLSD 81.2M
- ELVA 91.8M
- IPO Year
- CLSD 2016
- ELVA N/A
- Fundamental
- Price
- CLSD $0.95
- ELVA $2.29
- Analyst Decision
- CLSD Strong Buy
- ELVA Strong Buy
- Analyst Count
- CLSD 6
- ELVA 5
- Target Price
- CLSD $5.33
- ELVA $6.70
- AVG Volume (30 Days)
- CLSD 214.9K
- ELVA 71.7K
- Earning Date
- CLSD 03-11-2025
- ELVA 02-13-2025
- Dividend Yield
- CLSD N/A
- ELVA N/A
- EPS Growth
- CLSD N/A
- ELVA N/A
- EPS
- CLSD N/A
- ELVA N/A
- Revenue
- CLSD $7,703,000.00
- ELVA $43,693,000.00
- Revenue This Year
- CLSD N/A
- ELVA $55.29
- Revenue Next Year
- CLSD $91.87
- ELVA $58.94
- P/E Ratio
- CLSD N/A
- ELVA N/A
- Revenue Growth
- CLSD 248.39
- ELVA N/A
- 52 Week Low
- CLSD $0.80
- ELVA $1.67
- 52 Week High
- CLSD $2.12
- ELVA $4.24
- Technical
- Relative Strength Index (RSI)
- CLSD 43.06
- ELVA 39.90
- Support Level
- CLSD $1.00
- ELVA $2.45
- Resistance Level
- CLSD $1.09
- ELVA $2.60
- Average True Range (ATR)
- CLSD 0.07
- ELVA 0.16
- MACD
- CLSD -0.01
- ELVA -0.02
- Stochastic Oscillator
- CLSD 16.30
- ELVA 31.58
About CLSD Clearside Biomedical Inc.
Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.
About ELVA Electrovaya Inc.
Electrovaya Inc designs develop and manufacture proprietary lithium-ion batteries, battery systems, and battery-related products for energy storage, clean electric transportation and other specialized applications. It is a technology-focused company with extensive IP. The company generates revenue from the sale of batteries and battery systems. Business operations are segmented based on large format batteries and others. This technology offers enhanced safety and battery longevity. Geographically it earns key revenue from the United States.